rVSVDeltaG-ZEBOV-GP vaccine-induced seroreactivity to Bundibugyo virus: a cross-protection dilemma. Prasad AN, Geisbert TW. Lancet 2026;408:973-976.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Prasad AN, Geisbert TW. rVSVDeltaG-ZEBOV-GP vaccine-induced seroreactivity to Bundibugyo virus: a cross-protection dilemma. Lancet 2026;408:973-976.
PMID: 42721983